Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents	$ 22,132	$ 95,069
Due from related party	295,912	134,654
Promissory note	3,000
Total Current Assets	321,044	229,724
Patents	7,000	7,000
Total Assets	328,044	236,724
Current Liabilities
Accounts payable	797,908	797,908
Accrued expenses	1,986,726	1,953,934
Derivative liability	429,296
Notes payable	998,279	773,279
Convertible notes payable, net	117,534
Total Current Liabilities	4,329,743	3,525,121
Common stock (Par value $0.001 authorized 100,000,000 shares, issued and outstanding 92,928,477 and 79,813,071 at December 31, 2013 and December 31, 2012, respectively)	93,210	79,813
Common stock subscribed but not yet issued (0 and 1,500,000 at December 31, 2013 and December 31, 2012, respectively)		1,500
Subscription receivable		(10,000)
Additional paid in capital	30,078,730	26,580,244
Common stock-warrants	97,869	203,237
Deferred compensation	(12,609)	(12,500)
Accumulated deficit	(34,258,898)	(30,130,692)
Total stockholders deficit	(4,001,698)	(3,288,398)
Total Liabilities and stockholders deficit	$ 328,044	$ 236,723